DRUG PRICE DISCLOSURE FOR COLORADO PRESCRIBERS
NOTICE TO COLORADO PRESCRIBERS
This information is being provided pursuant to Colorado HB 19-1131. The information is accurate as of April 30, 2024. The prices listed are WAC prices, which represents Colgate Oral Pharmaceuticals, Inc. (COP) published catalog or list prices for its drug products sold to wholesalers, before any discount, rebate, or other price reduction. The WAC prices listed may differ from actual prices paid by customers and patients.
Generic Products
The listing of generic products in the disclosure forms represent drugs that are therapeutic equivalents of COP drugs, as defined by the U.S. Food and Drug Administration (FDA), and as listed in the FDA Approved Drug Products with Therapeutic Evaluations (commonly known as the Orange Book). The inclusion of a generic product in a form does not constitute an endorsement of the product as an appropriate interchangeable product that is safe and/or effective for a particular patient. Please refer to each generic product’s FDA-approved label and indications for further information regarding each drug and its safety and efficacy.
More Information
For more information on the price disclosure requirements, please contact the Colorado State Board of Pharmacy’s office:
State Board of Pharmacy
1560 Broadway, Suite 1350
Denver, CO 80202
Ph. (303) 894-7800 | Fax: (303) 894-7692 | Email: dora_pharmacyboard@state.co.us
Marketed Products
Colgate® PreviDent® 5000ppm (1.1% Sodium Fluoride) and PreviDent® Rinse (0.2% Neutral Sodium Fluoride)
PerioGard® (Chlorhexidine Gluconate Oral Rinse, USP , 0.12%) Alcohol Free
